Nizar Bitar

826 total citations
31 papers, 550 citations indexed

About

Nizar Bitar is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Nizar Bitar has authored 31 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Nizar Bitar's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (4 papers). Nizar Bitar is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (4 papers). Nizar Bitar collaborates with scholars based in Lebanon, Belgium and France. Nizar Bitar's co-authors include Mabel Aoun, Frédéric A. Meunier, Ali Shamseddine, Bassam Badran, Hussein Fayyad‐Kazan, Eva Hamade, Mohammad Fayyad‐Kazan, Arsène Burny, Philippe Martiat and Ahmad Daher and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Nizar Bitar

26 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nizar Bitar Lebanon 12 205 148 123 117 99 31 550
Asif Ali Pakistan 15 327 1.6× 224 1.5× 226 1.8× 72 0.6× 118 1.2× 82 871
Yinghu Chen China 12 380 1.9× 178 1.2× 93 0.8× 69 0.6× 112 1.1× 45 689
Jun Miyazaki Japan 18 265 1.3× 64 0.4× 214 1.7× 57 0.5× 139 1.4× 98 1.1k
Suzanne P. M. Lutgens Netherlands 11 182 0.9× 196 1.3× 70 0.6× 54 0.5× 128 1.3× 16 697
Pierre V. Candelaria United States 10 145 0.7× 53 0.4× 74 0.6× 39 0.3× 41 0.4× 21 439
Thales Allyrio Araújo de Medeiros Fernandes Brazil 16 253 1.2× 161 1.1× 215 1.7× 53 0.5× 356 3.6× 47 1.0k
Akito Nozaki Japan 18 201 1.0× 86 0.6× 84 0.7× 124 1.1× 559 5.6× 47 1.3k
Elaine Papa United States 13 324 1.6× 174 1.2× 80 0.7× 56 0.5× 142 1.4× 25 717
Andreas Heinold Germany 14 193 0.9× 56 0.4× 138 1.1× 179 1.5× 136 1.4× 36 797

Countries citing papers authored by Nizar Bitar

Since Specialization
Citations

This map shows the geographic impact of Nizar Bitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nizar Bitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nizar Bitar more than expected).

Fields of papers citing papers by Nizar Bitar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nizar Bitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nizar Bitar. The network helps show where Nizar Bitar may publish in the future.

Co-authorship network of co-authors of Nizar Bitar

This figure shows the co-authorship network connecting the top 25 collaborators of Nizar Bitar. A scholar is included among the top collaborators of Nizar Bitar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nizar Bitar. Nizar Bitar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oduwole, Olayiwola, Chengyi Ding, Nizar Bitar, et al.. (2025). Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults. PubMed. 2(1). 10–10. 2 indexed citations
2.
Kourié, Hampig Raphaël, Lewis Nasr, Fadi El Karak, et al.. (2024). Liquid biopsy as a tool for KRAS/NRAS/BRAF baseline testing in metastatic colorectal cancer. Clinics and Research in Hepatology and Gastroenterology. 48(8). 102417–102417. 1 indexed citations
3.
Bitar, Nizar, et al.. (2024). Complex Presentation of Multicentric Castleman Disease with Coexisting HIV, HHV‐8, and Other Opportunistic Infections. SHILAP Revista de lepidopterología. 2024(1). 8817064–8817064.
5.
Atallah, David, Nizar Bitar, Georges L. Chahine, et al.. (2023). Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon. Gynecologic Oncology Reports. 47. 101186–101186. 2 indexed citations
7.
Moussa, Mohamad, et al.. (2020). Dermatomyositis: A Presenting Clinical Vignette in a Patient With Breast Cancer. Cureus. 12(9). e10624–e10624. 2 indexed citations
8.
Moussa, Mohamad, et al.. (2020). Large cell neuroendocrine carcinoma of the colon with brain metastasis. International Journal of Surgery Case Reports. 76(C). 421–424. 2 indexed citations
9.
Fayyad‐Kazan, Mohammad, et al.. (2019). Circulating miR-29c, miR-30c, miR-193a-5p and miR-885-5p: Novel potential biomarkers for HTLV-1 infection diagnosis. Infection Genetics and Evolution. 74. 103938–103938. 15 indexed citations
10.
Diab‐Assaf, Mona, Raefa Abou Khouzam, K. Habib, et al.. (2015). Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.. PubMed. 8(1). 404–13. 11 indexed citations
11.
Fayyad‐Kazan, Hussein, Nizar Bitar, Mehdi Najar, et al.. (2013). Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. Journal of Translational Medicine. 11(1). 31–31. 140 indexed citations
12.
Farhat, Fadi, Sally Temraz, Joseph Kattan, et al.. (2011). Final results of a phase II study of liposomal cisplatin-vinorelbine combination as first-line treatment in HER2/neu negative metastatic breast cancer.. Journal of Clinical Oncology. 29(15_suppl). e11080–e11080. 1 indexed citations
13.
Farhat, Fadi, Sally Temraz, Joseph Kattan, et al.. (2011). A Phase II Study of Lipoplatin (Liposomal Cisplatin)/Vinorelbine Combination in HER-2/neu–Negative Metastatic Breast Cancer. Clinical Breast Cancer. 11(6). 384–389. 35 indexed citations
14.
Bitar, Nizar, Hiba El Hajj, Zaher K. Otrock, et al.. (2009). Adult T‐cell leukemia/lymphoma in the Middle East: first report of two cases from Lebanon. Transfusion. 49(9). 1859–1864. 10 indexed citations
15.
Shamseddine, Ali, Zaher K. Otrock, Maya Charafeddine, et al.. (2006). A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer. Oncology. 70(5). 330–338. 2 indexed citations
16.
Shamseddine, Ali, Aref Chehal, Yasser Abou Mourad, et al.. (2005). A Clinical Phase II Study of Cisplatinum and Vinorelbine (PVn) in Advanced Breast Carcinoma (ABC). American Journal of Clinical Oncology. 28(4). 393–398. 4 indexed citations
17.
Salem, Ziad, Pierre Zalloua, Aref Chehal, et al.. (2003). Effective treatment of hypereosinophilic syndrome with imatinib mesylate. The Hematology Journal. 4(6). 410–412. 20 indexed citations
18.
Seoud, Muhieddine, Ali Shamseddine, Ali Khalil, et al.. (1999). Tamoxifen and Endometrial Pathologies: A Prospective Study. Gynecologic Oncology. 75(1). 15–19. 42 indexed citations
19.
Bernier, Michel, Caroline Jacquy, Martine Massy, et al.. (1994). Myelomonocytic antigen abnormalities on neutrophils and monocytes in myelodysplastic syndromes. Leukemia Research. 18. 5–5. 1 indexed citations
20.
Meunier, Frédéric A., Mabel Aoun, & Nizar Bitar. (1992). Candidemia in Immunocompromised Patients. Clinical Infectious Diseases. 14(Supplement_1). S120–S125. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026